Biomarker Validation Following Sargramostim Treatment in Parkinson’s Disease
Condition(s):Parkinson’s Disease and ParkinsonismLast Updated:November 13, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Parkinson’s Disease and ParkinsonismLast Updated:November 13, 2023Active, not recruiting
Condition(s):Parkinson DiseaseLast Updated:November 18, 2023Active, not recruiting
Condition(s):Alzheimer’s DiseaseLast Updated:June 2, 2021Completed
Condition(s):COVID-19; SARS-CoV-2Last Updated:August 23, 2023Completed
Condition(s):Solid Tumor; Solid Tumor, AdultLast Updated:September 15, 2023Withdrawn
Condition(s):Covid19; SARS-CoV InfectionLast Updated:February 6, 2023Completed
Condition(s):COVID-19Last Updated:November 16, 2022Completed
Condition(s):Kidney Diseases; Kidney TransplantLast Updated:December 31, 2018Terminated
Condition(s):Autoimmune Pulmonary Alveolar ProteinosisLast Updated:August 3, 2021Completed
Condition(s):Alzheimer DiseaseLast Updated:January 8, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.